Kane Biotech Inc. announced that Mark Ahrens-Townsend has departed from the company as Chief Executive Officer as of September 10, 2018. Mark will remain close to the company and continue to work as an advisor. Marc Edwards, Director of Kane Biotech, is appointed as Interim CEO in addition to his current position on the Board of Directors.